Jens Juul Holst

Jens Juul Holst

Professor


  1. 2005
  2. Published

    Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes

    Fehse, F., Trautmann, M., Holst, Jens Juul, Halseth, A. E., Nanayakkara, N., Nielsen, L. L., Fineman, M. S., Kim, D. D. & Nauck, M. A., Nov 2005, In: The Journal of clinical endocrinology and metabolism. 90, 11, p. 5991-7 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    The use of glycaemic index tables to predict glycaemic index of breakfast meals

    Flint, A., Møller, B. K., Raben, Anne, Tetens, Inge , Holst, Jens Juul & Astrup, A., 2005, In: British Journal of Nutrition. 94, 1, p. 135-136 2 p.

    Research output: Contribution to journalLetterResearchpeer-review

  4. Published

    Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects.

    Frid, A. H., Nilsson, M., Holst, Jens Juul & Björck, I. M. E., 2005, In: American Journal of Clinical Nutrition. 82, 1, p. 69-75 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic beta-cells

    Haugaard, Steen Bendix, Andersen, Ove, Dela, Flemming, Holst, Jens Juul, Storgaard, H., Fenger, M., Iversen, J. & Madsbad, Sten, Jan 2005, In: European Journal of Endocrinology. Supplement. 152, 1, p. 103-12 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic beta-cells.

    Haugaard, S. B., Andersen, Ove, Dela, Flemming, Holst, Jens Juul, Storgaard, H., Fenger, M., Iversen, J., Madsbad, Sten, Haugaard, S. B., Andersen, Ove, Dela, F., Holst, J. J., Storgaard, H., Fenger, M., Iversen, J. & Madsbad, Sten, 2005, In: European Journal of Endocrinology. 152, 1, p. 103-112 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    GLP-1 receptor argonists for the treatment of diabetes

    Holst, Jens Juul, 2005, In: International Diabetes Monitor. 17, p. 11-18

    Research output: Contribution to journalJournal articleResearch

  8. Published

    For debate: Are antidiabetic actions of DPP-IV inhibitors mediated by glucagon-like peptide- 1?

    Holst, Jens Juul & Deacon, Carolyn F., 2005, In: Diabetologia. 48, p. 612-615

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Glucagon-like peptide 1: physiology and therapeutic potential

    Holst, Jens Juul, 2005, In: Endocrinology and Diabetes. 12, p. 56-62

    Research output: Contribution to journalJournal articleResearch

  10. Published

    Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors

    Holst, Jens Juul & Deacon, Carolyn F., Apr 2005, In: Diabetologia. 48, 4, p. 612-5 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Glucagon-like peptide-1 mediates the therapeutic actions of Dpp-IV inhibitors

    Holst, Jens Juul & Deacon, Carolyn F., 2005, In: Diabetologia. 48, p. 612-615

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 4207